• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于生物标志物优先级模型和致癌性调查的前列腺癌演变中关键 microRNA 及其机制的鉴定

Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey.

作者信息

Lin Yuxin, Miao Zhijun, Zhang Xuefeng, Wei Xuedong, Hou Jianquan, Huang Yuhua, Shen Bairong

机构信息

Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, China.

Department of Urology, Suzhou Dushuhu Public Hospital, Suzhou, China.

出版信息

Front Genet. 2021 Jan 15;11:596826. doi: 10.3389/fgene.2020.596826. eCollection 2020.

DOI:10.3389/fgene.2020.596826
PMID:33519899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7844321/
Abstract

Prostate cancer (PCa) is occurred with increasing incidence and heterogeneous pathogenesis. Although clinical strategies are accumulated for PCa prevention, there is still a lack of sensitive biomarkers for the holistic management in PCa occurrence and progression. Based on systems biology and artificial intelligence, translational informatics provides new perspectives for PCa biomarker prioritization and carcinogenic survey. In this study, gene expression and miRNA-mRNA association data were integrated to construct conditional networks specific to PCa occurrence and progression, respectively. Based on network modeling, hub miRNAs with significantly strong single-line regulatory power were topologically identified and those shared by the condition-specific network systems were chosen as candidate biomarkers for computational validation and functional enrichment analysis. Nine miRNAs, i.e., , and , were prioritized as key players for PCa management. Most of these miRNAs achieved high AUC values (AUC > 0.70) in differentiating different prostate samples. Among them, seven of the miRNAs have been previously reported as PCa biomarkers, which indicated the performance of the proposed model. The remaining and could serve as novel candidates for PCa predicting and monitoring. In particular, key miRNA-mRNA regulations were extracted for pathogenetic understanding. Here was selected as the case and and axis were found to be putative mechanisms during PCa evolution. In addition, signaling, prostate cancer, microRNAs in cancer etc. were significantly enriched by the identified miRNAs-mRNAs, demonstrating the functional role of the identified miRNAs in PCa genesis. Biomarker miRNAs together with the associated miRNA-mRNA relations were computationally identified and analyzed for PCa management and carcinogenic deciphering. Further experimental and clinical validations using low-throughput techniques and human samples are expected for future translational studies.

摘要

前列腺癌(PCa)的发病率呈上升趋势,其发病机制具有异质性。尽管针对PCa预防已积累了临床策略,但在PCa发生和进展的整体管理方面仍缺乏敏感的生物标志物。基于系统生物学和人工智能,转化信息学为PCa生物标志物的优先级排序和致癌研究提供了新的视角。在本研究中,整合了基因表达和miRNA-mRNA关联数据,分别构建了特定于PCa发生和进展的条件网络。基于网络建模,从拓扑结构上识别出具有显著强大单线调控能力的枢纽miRNA,并选择条件特异性网络系统共有的那些miRNA作为候选生物标志物,进行计算验证和功能富集分析。9种miRNA,即……被优先列为PCa管理的关键因素。这些miRNA中的大多数在区分不同前列腺样本时获得了较高的AUC值(AUC>0.70)。其中,有7种miRNA先前已被报道为PCa生物标志物,这表明了所提出模型的性能。其余的……可作为PCa预测和监测的新候选物。特别是,提取了关键的miRNA-mRNA调控关系以了解发病机制。这里选择……作为案例,发现……轴是PCa演变过程中的假定机制。此外,所鉴定的miRNA-mRNA显著富集了……信号通路、前列腺癌、癌症中的microRNA等,证明了所鉴定的miRNA在PCa发生中的功能作用。通过计算识别并分析了用于PCa管理和致癌解读的生物标志物miRNA及其相关的miRNA-mRNA关系。未来的转化研究有望使用低通量技术和人类样本进行进一步的实验和临床验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd4/7844321/f7d16ef23733/fgene-11-596826-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd4/7844321/d87770de9399/fgene-11-596826-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd4/7844321/6f486465b2e5/fgene-11-596826-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd4/7844321/71cff1e63792/fgene-11-596826-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd4/7844321/f7d16ef23733/fgene-11-596826-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd4/7844321/d87770de9399/fgene-11-596826-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd4/7844321/6f486465b2e5/fgene-11-596826-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd4/7844321/71cff1e63792/fgene-11-596826-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd4/7844321/f7d16ef23733/fgene-11-596826-g0004.jpg

相似文献

1
Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey.基于生物标志物优先级模型和致癌性调查的前列腺癌演变中关键 microRNA 及其机制的鉴定
Front Genet. 2021 Jan 15;11:596826. doi: 10.3389/fgene.2020.596826. eCollection 2020.
2
Multivariate competing endogenous RNA network characterization for cancer microRNA biomarker discovery: a novel bioinformatics model with application to prostate cancer metastasis.用于癌症微小RNA生物标志物发现的多变量竞争性内源性RNA网络特征分析:一种应用于前列腺癌转移的新型生物信息学模型
Precis Clin Med. 2022 Jan 10;5(1):pbac001. doi: 10.1093/pcmedi/pbac001. eCollection 2022 Mar.
3
microRNA Expression Profiling in Young Prostate Cancer Patients.年轻前列腺癌患者的微小RNA表达谱分析
J Cancer. 2020 Apr 7;11(14):4106-4114. doi: 10.7150/jca.37842. eCollection 2020.
4
Identification of Hub Genes Associated with Hypertension and Their Interaction with miRNA Based on Weighted Gene Coexpression Network Analysis (WGCNA) Analysis.基于加权基因共表达网络分析(WGCNA)的高血压相关枢纽基因鉴定及其与 miRNA 的相互作用。
Med Sci Monit. 2020 Sep 5;26:e923514. doi: 10.12659/MSM.923514.
5
Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.与结直肠癌进展密切相关的微小RNA及其基因靶点的计算分析
Microrna. 2019;8(1):68-75. doi: 10.2174/2211536607666180803100246.
6
Identification of miRNA-target gene regulatory networks in liver fibrosis based on bioinformatics analysis.基于生物信息学分析的肝纤维化中miRNA-靶基因调控网络的鉴定
PeerJ. 2021 Aug 6;9:e11910. doi: 10.7717/peerj.11910. eCollection 2021.
7
Development and validation of a urinary microRNA biomarker panel as a tool for early detection of prostate cancer in a Chinese population.开发和验证尿液 microRNA 生物标志物谱作为一种工具,用于在中国人群中早期检测前列腺癌。
Biomarkers. 2023 Jun;28(4):372-378. doi: 10.1080/1354750X.2023.2166587. Epub 2023 Apr 26.
8
Identification of key miRNAs in prostate cancer progression based on miRNA-mRNA network construction.基于miRNA-mRNA网络构建鉴定前列腺癌进展中的关键miRNA
Comput Struct Biotechnol J. 2022 Feb 7;20:864-873. doi: 10.1016/j.csbj.2022.02.002. eCollection 2022.
9
Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.从血清外泌体 microRNAs 中鉴定慢性萎缩性胃炎的非侵入性生物标志物。
BMC Cancer. 2019 Feb 8;19(1):129. doi: 10.1186/s12885-019-5328-7.
10
Differential expression of basal microRNAs' patterns in human dental pulp stem cells.人牙髓干细胞中基础微小RNA模式的差异表达
J Cell Mol Med. 2015 Mar;19(3):566-80. doi: 10.1111/jcmm.12381. Epub 2014 Dec 5.

引用本文的文献

1
Role of circulating MicroRNAs in prostate cancer diagnosis and risk stratification in the MCC Spain study.循环微小RNA在MCC西班牙研究中前列腺癌诊断及风险分层中的作用
Sci Rep. 2025 May 20;15(1):17517. doi: 10.1038/s41598-025-01373-9.
2
miRNA Signatures as Predictors of Therapy Response in Castration-Resistant Prostate Cancer: Insights from Clinical Liquid Biopsies and 3D Culture Models.微小RNA特征作为去势抵抗性前列腺癌治疗反应的预测指标:来自临床液体活检和3D培养模型的见解
Genes (Basel). 2025 Feb 1;16(2):180. doi: 10.3390/genes16020180.
3
Comprehensive investigation of matrix metalloproteinases in skin cutaneous melanoma: diagnostic, prognostic, and therapeutic insights.

本文引用的文献

1
Role of microRNAs in the development, prognosis and therapeutic response of patients with prostate cancer.微小 RNA 在前列腺癌患者的发展、预后和治疗反应中的作用。
Gene. 2020 Oct 30;759:144995. doi: 10.1016/j.gene.2020.144995. Epub 2020 Jul 25.
2
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.PI3K-AKT-mTOR 通路与前列腺癌:AR、MAPK 和 WNT 信号的十字路口。
Int J Mol Sci. 2020 Jun 25;21(12):4507. doi: 10.3390/ijms21124507.
3
MicroRNA-92a Targets SERTAD3 and Regulates the Growth, Invasion, and Migration of Prostate Cancer Cells via the P53 Pathway.
皮肤黑色素瘤中基质金属蛋白酶的综合研究:诊断、预后及治疗见解
Sci Rep. 2025 Jan 16;15(1):2152. doi: 10.1038/s41598-025-85887-2.
4
An Immunocompetent Environment Unravels the Proto-Oncogenic Role of miR-22.免疫活性环境揭示了miR-22的原癌基因作用。
Cancers (Basel). 2022 Dec 19;14(24):6255. doi: 10.3390/cancers14246255.
5
The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma.铜死亡相关基因特征可预测透明细胞肾细胞癌的预后并与免疫状态相关。
Front Genet. 2022 Dec 1;13:1061382. doi: 10.3389/fgene.2022.1061382. eCollection 2022.
6
Loss of miR-936 leads to acquisition of androgen-independent metastatic phenotype in prostate cancer.miR-936 的缺失导致前列腺癌细胞获得去势抵抗性转移表型。
Sci Rep. 2022 Oct 12;12(1):17070. doi: 10.1038/s41598-022-20777-5.
7
Hsa_circRNA_0040462: a sensor of cells' response to CAP treatment with double-edged roles on breast cancer malignancy.Hsa_circRNA_0040462:一种对 CAP 治疗反应的细胞感受器,在乳腺癌恶性肿瘤中具有双重作用。
Int J Med Sci. 2022 Mar 21;19(4):640-650. doi: 10.7150/ijms.66940. eCollection 2022.
8
Cancer Detection Using an Artificial Secretable MicroRNA Found in Blood and Urine.利用在血液和尿液中发现的一种人工可分泌微小RNA进行癌症检测。
Biomedicines. 2022 Mar 7;10(3):621. doi: 10.3390/biomedicines10030621.
9
Identification of key miRNAs in prostate cancer progression based on miRNA-mRNA network construction.基于miRNA-mRNA网络构建鉴定前列腺癌进展中的关键miRNA
Comput Struct Biotechnol J. 2022 Feb 7;20:864-873. doi: 10.1016/j.csbj.2022.02.002. eCollection 2022.
10
The Role of Androgen Receptor and microRNA Interactions in Androgen-Dependent Diseases.雄激素受体与 microRNA 相互作用在雄激素依赖性疾病中的作用。
Int J Mol Sci. 2022 Jan 28;23(3):1553. doi: 10.3390/ijms23031553.
微小RNA-92a靶向SERTAD3并通过P53途径调节前列腺癌细胞的生长、侵袭和迁移。
Onco Targets Ther. 2020 Jun 12;13:5495-5514. doi: 10.2147/OTT.S249168. eCollection 2020.
4
KLF5 Is Crucial for Androgen-AR Signaling to Transactivate Genes and Promote Cell Proliferation in Prostate Cancer Cells.KLF5对于雄激素-雄激素受体信号转导激活基因及促进前列腺癌细胞增殖至关重要。
Cancers (Basel). 2020 Mar 21;12(3):748. doi: 10.3390/cancers12030748.
5
Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion.Wnt信号传导驱动前列腺癌骨转移嗜性和侵袭。
Transl Oncol. 2020 Apr;13(4):100747. doi: 10.1016/j.tranon.2020.100747. Epub 2020 Mar 25.
6
Integrative Analysis of MicroRNA and Gene Interactions for Revealing Candidate Signatures in Prostate Cancer.整合分析微小RNA与基因相互作用以揭示前列腺癌的候选特征
Front Genet. 2020 Feb 27;11:176. doi: 10.3389/fgene.2020.00176. eCollection 2020.
7
Data-driven translational prostate cancer research: from biomarker discovery to clinical decision.数据驱动的前列腺癌转化研究:从生物标志物发现到临床决策
J Transl Med. 2020 Mar 7;18(1):119. doi: 10.1186/s12967-020-02281-4.
8
Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis.通过生物信息学分析鉴定前列腺癌骨转移中的关键基因和微小RNA。
FEBS Open Bio. 2020 Apr;10(4):674-688. doi: 10.1002/2211-5463.12805. Epub 2020 Mar 19.
9
miR-601 inhibits proliferation, migration and invasion of prostate cancer stem cells by targeting KRT5 to inactivate the Wnt signaling pathway.微小RNA-601通过靶向角蛋白5使Wnt信号通路失活,从而抑制前列腺癌干细胞的增殖、迁移和侵袭。
Int J Clin Exp Pathol. 2019 Dec 1;12(12):4361-4379. eCollection 2019.
10
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.